Selected scientific papers
This section contains a selection of Dr. Breggin's scientific articles spanning 1964 to the present. They can be arranged chronologically in order to facilitate an overview of his work over the years.
"Campaigns against racist federal programs by the Center for the Study of Psychiatry and Psychology." Journal of African American Men 1:No. 3, 3-22. Winter 1995/96.
"Coercion of Voluntary Patients in an Open Hospital." Archives of General Psychiatry 10:173-181, 1964. Reprinted with a new introduction in Edwards, R.B. (ed): Psychiatry and Ethics. Prometheus Books, 1982, and in Edwards, R.B. (ed): Ethics and Psychiatry. Amherst, New York, Prometheus Books, 1997.
"Confirming the Hazards of Stimulant Drug Treatment." The International Journal of Risk and Safety In Medicine, 13:199-120, 2000. Originally published in Ethical Human Sciences and Services, 2: 203-204, 2000.
Disabling the brain with electroshock (1981) 02/01/1981
"Disabling the Brain with Electroshock." Divergent Views in Psychiatry, M. Dongier and E. Wittkower, editors. Harper and Row, Hagerstown, MD, 247-271, 1981.
Electroshock therapy and brain damage: the acute organic brain syndrome as treatment (1984) 01/01/1984
"Electroshock Therapy and Brain Damage: The Acute Organic Brain Syndrome as Treatment." Behavior and Brain Sciences 7:24-25, 1984.
"Electroshock: Scientific, Ethical, and Political Issues." International Journal of Risk & Safety In Medicine, 11:5-40, 1998.
"Empathic Self-Transformation and Love in Individual and Family Therapy." The Humanistic Psychologist, 27:267-282, 1999.
"Empathic Self-Transformation in Therapy." Excerpt from Dimensions of Empathic Therapy , P. Breggin, G. Breggin and F. Bemak, editors. Springer Publishing Company, pp. 177 - 189, 2002.
"Empowering Social Work in the Era of Biological Psychiatry." (2001) [The annual Ephraim Lisansky ecture of the University of Maryland School of Social Work.] Ethical Human Sciences and Services, :197-206.
"Fluvoxamine as a Cause of Stimulation, Mania, and Aggression with a Critical Analysis of the FDA-Approved Label." International Journal of Risk and Safety in Medicine, 14: 71-86, 2002. Originally published in Ethical Human Sciences and Services, 4:211-227, 2002.